Lutronic Vision
Aesthetic, Vision, and Surgical lasers and related technology, was established in 1997 to bring intuitive, robust, versatile devices which are affordable and efficacious to the worldwide medical community. Committed to improving medicine, Lutronic partners with key opinion leaders to advance science and ensure efficacy of its systems. With a focus on physician needs and patient outcomes, Lutronic dedicates time and funding toward the development of devices that offer features and improvements not found in today’s market. Devoting more than 20% of revenue to R&D, Lutronic holds more than 130 current and pending patents. With more than 250 employees worldwide, Lutronic has offices in the US, Korea, China, Japan, and Europe, distributors world-wide, focused R&D centers in both the US and Korea, and is ever expanding.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical / Health Care
- Market Focus:
- Globally (various continents)
- Year Founded:
- 1997
About Us
Message from Haelyung Hwang, Chairman
My father had diabetes, and like many diabetic patients, he eventually developed diabetic retinopathy and suffered extreme vision loss. Experiencing his personal struggle with what it meant to lose sight sparked my interest in bringing novel laser technology to the leading cause of vision loss among adults, and this was a big part of the reason that Lutronic created Lutronic Vision in 2010. Lutronic has been a pioneer first in lasers and energy-based devices for dermatology and aesthetics, then in minimally invasive surgery, and now in ophthalmology...
Lutronic Vision is bringing to market the world’s first laser for Selective Retina Therapy™. Our system, named R:GEN™, is a fully integrated laser platform that safely and precisely targets the Retina Pigmented Epithelium to re-generate and re-store its function. Whereas older retinal photocoagulator lasers destroyed retinal tissue in an effort to preserve vision, R:GEN aims to revitalize retinal tissue by stimulating repair. Through this pioneering mechanism, we aim to introduce a new concept in ophthalmic retinal lasers that will ultimately lead to better vision and an improved lifestyle for patients and practitioners around the world.
Please explore in these pages how we have developed this exciting technology, and we will provide regular updates about our clinical progress and results.